Cargando…
Iatrogenic Kaposi's sarcoma unmasked by Vedolizumab in a patient with ulcerative colitis and well-controlled human immunodeficiency virus: A case report
Kaposi sarcoma (KS) was first described by Moritz Kaposi as a vascular tumor that mainly involves the skin but can affect any organ system. It is typically an acquired immunodeficiency syndrome defining illness but has emerged as a neoplasm also seen in patients on immunosuppressive therapy. Few KS...
Autores principales: | Ajao, Susanne O., Jayasingam, Rajasingam, Shaaban, Hamid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547680/ https://www.ncbi.nlm.nih.gov/pubmed/34760665 http://dx.doi.org/10.4103/IJCIIS.IJCIIS_92_20 |
Ejemplares similares
-
687. Iatrogenic Kaposi’s Sarcoma Following Treatment with Vedolizumab
por: Ajao, Susanne O, et al.
Publicado: (2020) -
Tofacitinib-Associated Iatrogenic Kaposi Sarcoma in a Patient With Ulcerative Colitis
por: Wetwittayakhlang, Panu, et al.
Publicado: (2021) -
Ozanimod-Associated Iatrogenic Kaposi Sarcoma in a Patient With Ulcerative Colitis
por: Sandlow, Sarah, et al.
Publicado: (2023) -
Iatrogenic colorectal Kaposi sarcoma complicating a refractory ulcerative colitis in a human immunodeficiency negative-virus patient
por: Hamzaoui, Lamine, et al.
Publicado: (2013) -
Human herpesvirus-8 positive iatrogenic Kaposi's sarcoma in the setting of refractory ulcerative colitis
por: Duh, Erica, et al.
Publicado: (2017)